close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis  

What's this?
Dollar2Point22
Implied share price

Sell Overvalued by 98.4%

5% margin of safety What's this?

EV / Revenue
Use Average
VRUS
Pharmasset, Inc.
JNJ
Johnson & Johnson
Change
NVS
Novartis AG (ADR)
Change
PFE
Pfizer Inc.
Change
MRK
Merck & Co., Inc.
Change
4.41 11330.43 4.34 4.16 4.58 4.67
All amounts in millions
from last financial year
         
Implied Share Price $2.22 $119.84 $86.39 $32.98 $58.36
Market Cap 10,361 322,696 212,603 207,930 171,277
Net Debt -163 -18,515 16,599 15,609 12,985
Enterprise Value (EV) 10,197 304,181 209,620 223,539 184,261
Revenue 0 70,074 50,359 48,851 39,498
Balance Sheet          
Total Assets 172 133,411 131,556 167,381 101,677
Total Liabilities 17 62,261 54,510 102,661 57,001
Shareholders Equity 154 71,150 77,046 64,720 44,676.0

Where are the EBIT and EBITDA figures?

Certain companies and those in specific industries (for example insurance) do not report financial results at the EBIT or EBITDA line. For these companies where Valuecruncher does not have EBIT or EBITDA numbers we exclude the valuation metrics driven by these figures. Valuecruncher makes our other valuation metrics available for these companies.

To learn more about comparison analysis, please read our guide to comparison analysis

Comments

No comments yet. Login to comment.